132
Views
4
CrossRef citations to date
0
Altmetric
Gynaecology case reports

Endometrioid adenofibroma arising in an endometriotic cyst

, &
Pages 352-354 | Published online: 02 May 2011

References

  • Kao GF, Norris HJ. 1979. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types. Obstetrics and Gynecology 54:729–736.
  • McCluggage WG, Bryson C, Lamki H et al. 2000. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. International Journal of Gynecological Pathology 19:276–279.
  • Nezhat F, Datta MS, Hanson V et al. 2008. The relationship of endometriosis and ovarian malignancy: a review. Fertility and Sterility 90:1559–1570.
  • Roth LM, Czernobilsky B, Langley FA. 1981. Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors: benign, proliferating, and malignant. Cancer 48:1838–1845.
  • Seidman JD, Russell P, Kurman RJ. 2002. Surface epithelial tumors of the ovary. In: Kurman RJ (ed.) Blaustein's pathology of the female genital tract, 5th edn. New York: Springer-Verlag. p 791–904.
  • Sugiyama T, Nishida T, Kataoka A et al. 1997. A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types. European Journal of Obstetrics, Gynecology and Reproductive Biology 72:47–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.